Coverage rate of opportunistic and organised breast cancer screening in France: Department-level estimation

Autor: Cécile, Quintin, Edouard, Chatignoux, Julie, Plaine, Françoise F, Hamers, Agnès, Rogel

Publikováno v: Cancer Epidemiology. 81:102270

In France, the national breast cancer screening programme (NBCSP), targeting women aged 50-74 years was rolled out nationwide in 2004. It aims at reducing breast cancer mortality. In addition to the NBCSP, the use of opportunistic screening is permit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b7e31f957c609eabbbcef552ee4560
https://doi.org/10.1016/j.canep.2022.102270

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France

Autor: Anne Lallemand, Laura Reques, Françoise F. Hamers, Najat Lahmidi, Ken Haguenoer, Ezequiel Aranda-Fernández, Julie Bottero, Camille Rolland, Antonio Lazzarino, Niklas Luhmann, Guy Launoy, Christine Bergeron

Publikováno v: BMC Women's Health
BMC Women's Health, BioMed Central, 2021, 21 (1), pp.221. ⟨10.1186/s12905-021-01356-8⟩
BMC Women's Health, Vol 21, Iss 1, Pp 1-14 (2021)

BackgroundThe purpose of this study was to compare cervical cancer screening by pap smear (PS) versus preliminary HPV testing based on self-collected samples (SC-HPV).MethodsInterventional study among underprivileged women from 25 to 65 years old in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca50025fe060d080fb6b13c237b93ad1
https://doi.org/10.1186/s12905-021-01356-8

Rectal Lymphogranuloma Venereum, France

Autor: Magid Herida, Patrice Sednaoui, Elisabeth Couturier, Didier Neau, Maïthe Clerc, Catherine Scieux, Gerard Kreplak, Véronique Goulet, Françoise F Hamers, Bertille de Barbeyrac

Publikováno v: Emerging Infectious Diseases, Vol 11, Iss 3, Pp 505-506 (2005)

Externí odkaz: https://doaj.org/article/b46a6388eaa24137b5ed5253c98f9d03

Health-state utility estimates for health technology assessment: a review of the manufacturers’ submissions to the French National Authority for Health

Autor: Salah Ghabri, Catherine Le Galès, Françoise F. Hamers

Publikováno v: Expert Review of Pharmacoeconomics and Outcomes Research
Expert Review of Pharmacoeconomics and Outcomes Research, Expert Reviews, 2017, 17 (5), pp.489-494. ⟨10.1080/14737167.2017.1289088⟩

International audience; Background: Our aim was to review the selection and methods used for deriving health state utility (HSU) estimates included in the cost-utility analyses (CUA) submitted by manufacturers to the National Authority for Health (HA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5bd563e34d0ff8f549e13c39e4d3877
https://hal-cnrs.archives-ouvertes.fr/hal-03479968

Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers’ Submissions to the French National Authority for Health

Autor: Françoise F. Hamers, Salah Ghabri, Jean Michel Josselin

Publikováno v: PharmacoEconomics
PharmacoEconomics, Springer Verlag, 2016, 34 (6), pp.617-624. ⟨10.1007/s40273-016-0381-4⟩
PharmacoEconomics, 2016, 34 (6), pp.617-624. ⟨10.1007/s40273-016-0381-4⟩

International audience; ObjectivesThe objective of this paper was to evaluate how uncertainty has been accounted for in the cost-effectiveness analyses (CEAs) submitted by manufacturers to the French National Authority for Health (HAS) and to identif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86b5c1bb0e56fd7b54656d929a00a07
https://halshs.archives-ouvertes.fr/halshs-01271282